STATCenter·
STAT+: Pharmalittle: We’re reading about an AstraZeneca COPD win, the FDA filling key jobs, and more
An AstraZeneca drug reduced the dangerous flare-ups that worsen COPD in a pair of late-stage trials
Read at STAT →
An AstraZeneca drug reduced the dangerous flare-ups that worsen COPD in a pair of late-stage trials

<iframe src="https://statesidedaily.com/embed/cluster/31cf492f7c471e65e9309cca2627591979e24883" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="STAT+: Pharmalittle: We’re reading about an AstraZeneca COPD win, the FDA filling key jobs, and more"></iframe>

